Wyeth said it had pay30 million to buy privately held biotechnology company Thiakis Ltd. The Madison, New Jersey-based company will make additional payments up to $120 million to private investors of Thiakis if its pipeline achieves certain development milestones and clinical objectives
.

Chicago-based Abbott Laboratories announced a total payment of 175 million dollars to purchase the remaining equity to take over California based Ibis Biosciences Inc. a specialized company in medical diagnostic.

King Pharmaceutical Inc said is exploring alternative financing structure for its $1.6 billion proposed acquisition of Alpharma Inc. Early this week, King agreed to acquire Alpharma, ending a takeover battle and expanding King´s presence into the pain market

Swiss drugmaker Roche Holding AG announced that signed a definitive merger agreement to acquire all the outstanding shares of Memory Pharmaceuticals Inc. in an all-cash transaction for some $50 million. Both companies are already in partnered programmes for disorders such as Alzheimer´s disease and schizophrenia.

King Pharmaceuticals’ and Alpharma Inc’s boards signed an agreement in which the Bristol, Tennessee-based company will acquire Bridgewater, New Jersey-based for about $1.6 billion. The amount is the same that Alpharma had rejected as too low last month and ends a takeover fight that began with King’s $1.4 billion offer last August.

UBS AG bankers were behind Eli Lilly & Co striking the $ 6.5 billion-dollar deal to acquire ImClone Systems Inc, while their own research analyst was telling Eli Lilly it was paying too much.

Bristol-Myers Squibb Co. will sell its 17 percent stake in ImClone Systems Inc., the biotechnology company that agreed today to be bought by Eli Lilly & Co. for $6.5 billion. However, Bristol will continue to co-market in the U.S. ImClone´s only product, the blockbuster drug Erbitux

Sanofi-Aventis said that it has agreed to buy Czech generic drug maker Zentiva for around $ 2.6 billion after raising its previous bid by almost 10 percent. However, the bid is conditional on gaining more than 50 percent of control over Zentiva, along with competition clearance.

Sweddish Meda AB has reached an agreement with the Swiss pharma company Roche Holding to acquire four of their pharmaceutical products. Further details.

Shire Plc, the U.K.´s third-biggest drugmaker, agreed to pay $520.7 million in cash for Germany´s Jerini AG to add Firazyr, a treatment for hereditary angioedema, a fatal and rare tissue swelling condition.

Bristol-Myers Squibb Co announced signing an agreement with Kosan Biosciences Inc, a cancer therapeutics company, for an approximately $ 190 million dollars acquisition of the biotech firm, a transaction giving BMS two pipeline cancer treating drugs in the Hsp90 inhibitor and epothilone classes. Further details.